Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Humanized anti-human interferon (IFN) alpha antibody and application thereof

An antibody and whole antibody technology, applied in the fields of application, antibody, anticytokine/lymphokine/interferon immunoglobulin, etc.

Active Publication Date: 2015-01-21
INST OF BIOENG ACAD OF MILITARY MEDICAL SCI OF THE CHINESE
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, a large number of studies have shown that a variety of autoimmune diseases may be related to the high expression of type I interferon

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Humanized anti-human interferon (IFN) alpha antibody and application thereof
  • Humanized anti-human interferon (IFN) alpha antibody and application thereof
  • Humanized anti-human interferon (IFN) alpha antibody and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] Example 1 Screening and Identification of Specific Human Anti-human Interferon Alpha Antibody

[0057] 1. Materials and methods:

[0058]1. Materials: A large-capacity fully synthetic phage single-chain antibody library was constructed by the Academy of Military Medical Sciences of the Chinese People's Liberation Army (ZL200910091261.8), with a library capacity of 1.35×10 10 . Antigens for screening the antibody library were human IFNα_2b recombinantly expressed in Escherichia coli (ProSpec-Tany, Israel) and HSA-IFNα_1b and HSA-IFNα_2b fused with human serum albumin (HSA) (Antibody Online Company). The bacterial strain is XL1-Blue (Stratagene, USA); the phage used is M13KO7 (Invitrogene, USA). The eukaryotic expression vectors pABG1, pABK and pABL are preserved in our laboratory. The vector structure map is shown in Figure 1. Mammalian cells FreeStyle TM HEK293-T was purchased from Invitrogene. The variable region nucleic acid sequence synthesis service of MedImmune...

Embodiment 2

[0082] Example 2 Analysis of AIA22 affinity and neutralizing activity in vitro

[0083] 1. Materials and methods:

[0084] 1. Materials: CM5 chips were purchased from GE Healthcare Life Sciences. IFNα_1, IFNα_2, IFNα_4, IFNα_5, IFNα_6, IFNα_8, IFNα_10, IFNα_14, IFNα_16, IFNα_17, IFNα_21 and other subtypes were purchased from PBL Company (product number 11002-1). Daudi cells (human Burkitt's lymphoma cells) were purchased from the Cell Bank of the Type Culture Collection Committee of the Chinese Academy of Sciences. CCK-8 was purchased from Japan Dojin Chemical Co., Ltd. Neonatal bovine serum NCS was purchased from PAA Company. RPMI1640 cell culture medium was purchased from Gibco. Other related materials are the same as in Example 1.

[0085] 2. Method

[0086] 2.1 BIAcore3000 System Determination of Antibody Affinity

[0087] In this example, the BIAcore3000 system was used to detect the affinity of AIA22 to IFNα_2b and HSA-IFNα_1b. The specific steps are as follows: ...

Embodiment 3

[0116] Example 3 AIA22 light and heavy chain CDR region alanine scanning and mutant evaluation

[0117] 1. Materials and methods:

[0118] 1. Materials: Fortebio Octet system and Anti-Human IgG Fc Capture were purchased from iResearch Biotechnology (Shanghai) Co., Ltd. Other relates to material with embodiment 1, embodiment 2.

[0119] 2. Method

[0120] 2.1 Alanine scanning

[0121] Site-directed mutagenesis primers were designed to scan the 6 CDR regions of the AIA22 antibody for alanine, and if the position was alanine, it was mutated to Gly and Ser respectively. Methods The plasmid site-directed mutagenesis method was used, and the specific implementation method can refer to the literature [Wang Ronghao, Chen Ruichuan, Liu Runzhong. An optimized method for fast point mutations. Journal of Xiamen University (Natural Science Edition), 2008, Vol47, sup2, 282-285].

[0122] 2.2. ELISA detection of relative affinity

[0123] Antigens (HSA-IFNα_1b and HSA-IFNα_2b) were di...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a humanized anti-human interferon (IFN) alpha antibody, as well as a coding gene and an application thereof. By combining and applying gene engineering means and phage surface display technology, a plurality of subtype anti-human IFN alpha gene engineering single chain antibodies are screened from a fully synthetic single chain human antibody library, and a gene sequence of a variable region of the antibodies is obtained, holistic monoclonal Fab and IgG antibody recombinant carrier are constructed on that basis, and a high-purity antibody molecule is obtained by expression and purification of mammalian cells. The affinity of combination of the obtained antibody Fab and human IFN alpha-2 is not more than 0.5nM, and the affinity of combination of the obtained antibody Fab and IFN alpha-2 is not more than 5nM. The antibody can be used for effectively blocking the biological activity of IFN alpha-2 and other multiple subtype IFN alpha at a cellular level. The humanized anti-human IFN alpha antibody provides a specific antibody medicine for treatment of IFN related diseases, such as systemic lupus erythematosus and other autoimmunity diseases.

Description

technical field [0001] The present invention relates to the preparation and application of human genetically engineered antibodies for treatment, mainly targeting various subtypes of human α interferon (interferon alpha, IFNα), and inhibiting the biological function of IFNα by blocking the combination of IFNα and IFNα receptors. function, so as to achieve the treatment of systemic lupus erythematosus and other autoimmune diseases related to IFNα with genetically engineered antibodies. Background technique [0002] Interferon (interferon, IFN) is a kind of glycoprotein produced by viruses or other kinds of interferon inducers to stimulate the reticuloendothelial system, macrophages, lymphocytes and somatic cells. Interferon is a broad-spectrum antiviral agent, which does not directly kill or inhibit viruses, but mainly makes cells produce antiviral proteins through the action of cell surface receptors, thereby inhibiting virus replication; at the same time, it can also enhanc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/24C12N15/13C12N15/85C07K19/00A61K39/395A61K47/48A61K51/10A61P37/02A61P19/02A61P17/06A61P17/00A61P3/10A61P21/00
Inventor 孙志伟王双杜鹏仇玮祎余云舟
Owner INST OF BIOENG ACAD OF MILITARY MEDICAL SCI OF THE CHINESE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com